“american-academy-of-neurology” Archives

in
Entry Author Date Location
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3 03/27/19 San Diego
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow 04/25/18 Boston
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
San Diego Life Sciences Roundup: Health IT, Illumina, & More 03/22/13 San Diego
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Tysabri May Promote Healing Around Nerves, Study Says 04/28/09 Boston
Biogen Idec To Show Off MS Drugs at Seattle Neurology Meeting 04/24/09 Boston
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri 08/01/08 Boston
Page 1 of 1